Infections: all 6,702 studies

Page 12 of 68. Open to participants first (801), then studies with results posted, then the rest; newest registration first within each.

• GSK3640254 First Time in Human (FTIH) Study in Healthy VolunteersCompletedNCT03231943Phase 1Results posted
• A Pharmacokinetics Study of MK-7655A in Pediatric Participants With Gram-negative Infections (MK-7655A-020)CompletedNCT03230916Phase 1Results posted
• MK-7625A Versus Meropenem in Pediatric Participants With Complicated Urinary Tract Infection (cUTI) (MK-7625A-034)CompletedNCT03230838Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-InfectionCompletedNCT03222583Phase 3Results posted
• Study of Aztreonam for Inhalation in Children With Cystic Fibrosis and New Infection of the Airways by Pseudomonas Aeruginosa BacteriaTerminatedNCT03219164Phase 3Results posted
• A Pharmacokinetic Study of Tedizolid Phosphate in Pediatric Participants With Gram-Positive Infections (MK-1986-014)CompletedNCT03217565Phase 1Results posted
• MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035)CompletedNCT03217136Phase 2Results posted
• Study to Evaluate Effects of Vorinostat and HXTC on Persistent HIV-1 Infection in HIV-Infected Subjects Started on Antiretroviral Therapy (ART)CompletedNCT03212989Phase 1Results posted
• Topical Antibiotic Prophylaxis for EyelidsCompletedNCT03199911Phase 4Results posted
• ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active ComparatorCompletedNCT03198507Phase 3Results posted
• ECOSPOR IV: An Open-Label Study Evaluating SER-109 in Recurrent Clostridioides Difficile InfectionCompletedNCT03183141Phase 3Results posted
• ECOSPOR III - SER-109 Versus Placebo in the Treatment of Adults With Recurrent Clostridium Difficile InfectionCompletedNCT03183128Phase 3Results posted
• Bezlotoxumab (MK-6072) Versus Placebo in Children With Clostridium Difficile Infection (CDI) (MK-6072-001)CompletedNCT03182907Phase 3Results posted
• Clinical Trial of Efficacy and Safety of Anaferon for Children Liquid Dosage Form in the Treatment of Acute Upper Respiratory InfectionsCompletedNCT03162458Phase 3Results posted
• Effect of Rifabutin on the Pharmacokinetics of Oral Cabotegravir in Healthy SubjectsCompletedNCT03149848Phase 1Results posted
• Incidence and Risk Factors for Surgical Site Infection After Intramedullary Nailing of Femoral and Tibial FracturesCompletedNCT03148067Results posted
• Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes InfectionTerminatedNCT03146403Phase 2Results posted
• Rifaximin Associated With Classic Triple Therapy for the Eradication of Helicobacter Pylori InfectionCompletedNCT03124199Phase 3Results posted
• Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-InfectionCompletedNCT03119025Phase 1/2Results posted
• Project PROTECT: Protecting Nursing Homes From Infections and HospitalizationCompletedNCT03118232Phase 4Results posted
• Efficacy and Safety of Elbasvir (MK-8742) + Grazoprevir (MK-5172) in Treatment-Naïve/Treatment-Experienced (TN/TE) French Participants With Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection (MK-5172-096)CompletedNCT03111108Phase 4Results posted
• VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and AdolescentsCompletedNCT03110770Phase 2Results posted
• Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. DiffCompletedNCT03110133Phase 2Results posted
• Phase 2B/3 Double-blinded Placebo-controlledCompletedNCT03107377Phase 2/3Results posted
• The ICON Study: Outcomes After FMT for Patients With IBD and CDICompletedNCT03106844Phase 1/2Results posted
• Reducing Urinary Tract Infection Rates Using a Controlled Aseptic Protocol for Catheter InsertionCompletedNCT03101371Phase 2Results posted
• Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Tract InfectionCompletedNCT03099863Phase 4Results posted
• Use of a Rapid Test for Gonorrhea & Chlamydia for Women Presenting With Possible Sexually Transmitted InfectionsTerminatedNCT03098394Not applicableResults posted
• Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) InfectionCompletedNCT03074331Phase 3Results posted
• A Study to Assess the Efficacy of a Heterologous Prime/Boost Vaccine Regimen of Ad26.Mos4.HIV and Aluminum Phosphate-Adjuvanted Clade C gp140 in Preventing Human Immunodeficiency Virus (HIV) -1 Infection in Women in Sub-Saharan AfricaTerminatedNCT03060629Phase 2Results posted
• Feasibility of SBIRT-PNCompletedNCT03057119Not applicableResults posted
• Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus (HIV)-1 Infected AdultsCompletedNCT03045861Phase 2Results posted
• Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Viral Intestinal Infections in ChildrenCompletedNCT03039699Phase 4Results posted
• Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in ChildrenCompletedNCT03039621Phase 4Results posted
• Ledipasvir/Sofosbuvir in Adults With Chronic Hepatitis C Virus (HCV) Infection Who Are on Dialysis for End Stage Renal DiseaseCompletedNCT03036839Phase 2Results posted
• Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract InfectionsCompletedNCT03032510Phase 3Results posted
• Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir in Adolescents and Children With Chronic HCV InfectionCompletedNCT03022981Phase 2Results posted
• Comparison Between Wound Vacuum Dressing and Standard Closure to Reduce Rates of Surgical Site InfectionsCompletedNCT03021668Not applicableResults posted
• Tolerability, Safety, and Efficacy of Tedizolid as Oral Treatment for Bone and Joint Infections (OTTER)CompletedNCT03009045Phase 2Results posted
• Cryptococcal Antigen Screening Plus SertralineTerminatedNCT03002012Phase 3Results posted
• Cranberry Effect on Urinary Tract InfectionsCompletedNCT02996981Results posted
• Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection and Decompensated CirrhosisCompletedNCT02996682Phase 3Results posted
• Screening to Prophylax Against Clostridium Difficile Infection -CompletedNCT02996487Phase 4Results posted
• Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 Weeks in Participants With Chronic HCV Infection and Child-Pugh-Turcotte Class C CirrhosisCompletedNCT02994056Phase 2Results posted
• Phase 3 Study of BK1310 in Healthy InfantsCompletedNCT02992925Phase 3Results posted
• Comparative Effectiveness of Treatment Options for Genital Herpes Infection to Reduce Adverse Pregnancy OutcomesCompletedNCT02986802Results posted
• Evaluation of Moderate to Severe Influenza Outcomes in ChildrenCompletedNCT02979626Results posted
• Dose Ranging Study of ALX-0171 in Infants Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract InfectionCompletedNCT02979431Phase 2Results posted
• Levofloxacin Triple and Bismuth Quadruple Therapies for Rescue Treatment of H Pylori InfectionCompletedNCT02978157Not applicableResults posted
• Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)CompletedNCT02971007Phase 2Results posted
• A Study to Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and the Republic of BelarusCompletedNCT02968173Phase 3Results posted
• A Study of of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 InfectionCompletedNCT02966795Phase 3Results posted
• Effectiveness of a Online Training Program With a Clinical Procedure Standardized in Units of Nursing (CPSUN)CompletedNCT02965989Not applicableResults posted
• Evaluation of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)CompletedNCT02961764Phase 4Results posted
• Effect of Standard Normothermia Protocol On Surgical Site InfectionsCompletedNCT02961244Not applicableResults posted
• Rapid Diagnostics for Upper Respiratory Infections in the Emergency DepartmentCompletedNCT02957136Not applicableResults posted
• Oral Vancomyin for Primary Clostridium Difficile Infection Prophylaxis in Patients Receiving High-Risk AntibioticsCompletedNCT02951702Phase 4Results posted
• Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected AdultsActive, not recruitingNCT02951052Phase 3Results posted
• Assessment of Infection Control, Practice Efficiency, and Health Economics of Sheathed Versus Standard CystoscopyCompletedNCT02922868Not applicableResults posted
• Precision Diagnosis of Acute Infectious Diseases; Neuroinflammatory CohortCompletedNCT02910037Not applicableResults posted
• Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSICompletedNCT02877927Phase 3Results posted
• Nitric Oxide Releasing Solution (NORS) Footbath to Treat Athlete's FootCompletedNCT02871011Phase 2Results posted
• Performance of Nucleic Acid Amplification Tests for the Detection of NG and CTCompletedNCT02870101Not applicableResults posted
• Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer ChemotherapyCompletedNCT02868242Phase 2Results posted
• Prevena™ vs Dermabond in Groin Wound Infections in Vascular SurgeryCompletedNCT02836990Not applicableResults posted
• An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Participants (Gemini 2)CompletedNCT02831764Phase 3Results posted
• An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1)CompletedNCT02831673Phase 3Results posted
• Study to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healthy AdultsCompletedNCT02826798Phase 1Results posted
• Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 or 24 Weeks in Participants With Chronic Genotype 1 or 2 Hepatitis C Virus Infection Who Have Previously Failed a Direct-Acting Antiviral-Containing RegimenCompletedNCT02822794Phase 3Results posted
• Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSACompletedNCT02814916Phase 3Results posted
• Perioperative Antibiotic Therapy to Prevent Cardiac Implantable Electronic Device Infections.CompletedNCT02809131Phase 3Results posted
• Hallmarks of Protective Immunity in Sequential Rhinovirus Infections in HumansCompletedNCT02796001Phase 1/2Results posted
• Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal InfectionsCompletedNCT02784704Phase 3Results posted
• Sofosbuvir/Velpatasvir Fixed Dose Combination in Participants With Chronic Hepatitis C Virus Infection Who Have Received a Liver TransplantCompletedNCT02781571Phase 2Results posted
• Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir FDC and Ribavirin in Participants With Chronic Genotype 3 HCV Infection and CirrhosisCompletedNCT02781558Phase 2Results posted
• Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 InfectionCompletedNCT02778204Phase 1Results posted
• Topical Antibiotic Treatment for Spine Surgical Site InfectionCompletedNCT02776774Results posted
• The Value of Home Chlorhexidine Pre-Surgical Wash Before Spine SurgeryCompletedNCT02767427Not applicableResults posted
• Study of Obese Patients Comparing Two Vancomycin Loading Dose RegimensCompletedNCT02764359Not applicableResults posted
• Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP InfectionsCompletedNCT02753946Phase 2/3Results posted
• Modulating the Impact of Critical Events in Early HIV Infection: Effect of ART Initiation and Alcohol UseCompletedNCT02744040Not applicableResults posted
• Study of Ceftolozane/Tazobactam (MK-7625A) in Combination With Metronidazole in Japanese Participants With Complicated Intra-abdominal Infection (MK-7625A-013)CompletedNCT02739997Phase 3Results posted
• Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Participants With Chronic Genotype 2 HCV InfectionCompletedNCT02738333Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)CompletedNCT02738138Phase 3Results posted
• Trial of Post-Dated Delayed Antibiotic PrescriptionsCompletedNCT02732847Not applicableResults posted
• Study of Ceftolozane/Tazobactam (MK-7625A) in Japanese Participants With Uncomplicated Pyelonephritis and Complicated Urinary Tract Infection (MK-7625A-014)CompletedNCT02728089Phase 3Results posted
• Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination in Participants With Chronic Hepatitis C Virus InfectionCompletedNCT02722837Phase 3Results posted
• Surgical Site Infections After Liver Transplantation Based on Perioperative AntibioticsCompletedNCT02717273Phase 3Results posted
• Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection Among Men and Transgender Persons Who Have Sex With MenCompletedNCT02716675Phase 2Results posted
• Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative PathogensCompletedNCT02714595Phase 3Results posted
• Dose-finding Study to Assess the Efficacy, Safety and Tolerability of Tobramycin Inhalation Powder in Patients With Non-Cystic Fibrosis Bronchiectasis and Pulmonary P. Aeruginosa InfectionCompletedNCT02712983Phase 2Results posted
• Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV TreatmentCompletedNCT02707601Phase 3Results posted
• Safety and Pharmacokinetics of UV-4B Solution Administered Orally as Multiple Ascending Doses to Healthy SubjectsTerminatedNCT02696291Phase 1Results posted
• A Comparison of Fidaxomicin and Vancomycin in Patients With CDI Receiving Antibiotics for Concurrent InfectionsCompletedNCT02692651Phase 4Results posted
• Effect of Peri-operative Supplemental Oxygen in Wound Infection After AppendectomyCompletedNCT02687217Not applicableResults posted
• Superficial and Cutaneous Fungal Infections Among Drug-users in Northeast Region of IranCompletedNCT02681458Results posted
• Safety and Therapeutic Efficacy of the VRC01 Antibody in Patients Who Initiated Antiretroviral Therapy During Early Acute HIV InfectionCompletedNCT02664415Phase 2Results posted
• Determine the PK and Safety and Tolerability of ATM-AVI for the Treatment of cIAIs in Hospitalized Adults (REJUVENATE)CompletedNCT02655419Phase 2Results posted
• Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream InfectionCompletedNCT02651428Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Renally Impaired Adults With Chronic Hepatitis C Virus Genotype 1 - 6 InfectionCompletedNCT02651194Phase 3Results posted

← Infections overview